Dr Reddys Laboratories (RDY) Research & Development (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Research & Development of $66.0 million for Q2 2023, up 10.0% quarter-over-quarter from $60.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Research & Development (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Research & Development history runs 15 years deep, the most recent figure standing at $66.0 million for Q2 2023.
- In Q2 2023, Research & Development changed N/A year-over-year to $66.0 million; the TTM figure through Jun 2023 stood at $191.0 million (changed N/A YoY), while the FY2026 annual figure was $256.0 million, down 20.0% from the prior year.
- Research & Development for Q2 2023 stood at $66.0 million, up from $60.0 million in the prior quarter.
- The five-year high for Research & Development was $66.0 million in Q2 2023, with the low at $59.0 in Q3 2022.
- The 5-year median for Research & Development is $58.0 million (2020), against an average of $53.3 million.
- The sharpest annual moves came in 2019 and 2020: Research & Development slipped 12.07% in 2019, then climbed 17.65% in 2020.
- Dr Reddys Laboratories' Research & Development stood at $55.0 million in 2019, then increased by 1.82% to $56.0 million in 2020, then increased by 7.14% to $60.0 million in 2021, then climbed by 8.33% to $65.0 million in 2022, then rose by 1.54% to $66.0 million in 2023.
- Business Quant data shows RDY's Research & Development at $66.0 million in Q2 2023, $60.0 million in Q1 2023, and $65.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 154.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 66.00 Mn |
| Mar 31, 2023 | 60.00 Mn |
| Dec 31, 2022 | 65.00 Mn |
| Sep 30, 2022 | 59.00 |
| Jun 30, 2021 | 60.00 Mn |
| Mar 31, 2021 | 61.00 Mn |
| Sep 30, 2020 | 56.00 Mn |
| Jun 30, 2020 | 60.00 Mn |
| Mar 31, 2020 | 54.00 Mn |
| Sep 30, 2019 | 55.00 Mn |
| Jun 30, 2019 | 51.00 Mn |
| Mar 31, 2019 | 51.00 Mn |
| Dec 31, 2018 | 63.00 Mn |
| Sep 30, 2018 | 53.00 Mn |
| Jun 30, 2018 | 58.00 Mn |
| Mar 31, 2018 | 57.00 Mn |
| Dec 31, 2017 | 63.00 Mn |
| Sep 30, 2017 | 72.00 Mn |
| Dec 31, 2016 | 75.00 Mn |
| Sep 30, 2016 | 73.00 Mn |